IDH and CIC mutations provide prognostic information for grade II and III gliomas

(NRG Oncology) NRG Oncology investigators have identified two biomarkers that are prognostic of overall and progression-free survival for patients with lower-grade gliomas.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news